Sikander Ailawadhi

机构：Mayo Clinic, Jacksonville College, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0002-8377-8111

发表论文 706 篇 · 总被引 7578 次 · h-index 43

代表论文

• Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma (2025 · Blood Cancer Journal · 被引 13)
• Investigating the Role of Dexamethasone Prophylaxis for the Risk Reduction of Immune Effector Cell Delayed Neurotoxicity in Cilta-Cel Treated Patients (2026 · Transplantation and Cellular Therapy · 被引 2)
• POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia (2026 · Blood Advances · 被引 2)
• Diagnosis and management of immune effector cell–associated enterocolitis after ciltacabtagene autoleucel (2026 · Blood Advances · 被引 1)
• Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US) (2026 · Expert Review of Hematology · 被引 1)
• Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity (2026 · Blood Cancer Journal)